Literature DB >> 8550854

Comparison of the time courses of insulin and the portal signal on hepatic glucose and glycogen metabolism in the conscious dog.

M J Pagliassotti1, L C Holste, M C Moore, D W Neal, A D Cherrington.   

Abstract

To investigate the temporal response of the liver to insulin and portal glucose delivery, somatostatin was infused into four groups of 42-h-fasted, conscious dogs (n = 6/group), basal insulin and glucagon were replaced intraportally, and hyperglycemia was created via a peripheral glucose infusion for 90 min (period 1). This was followed by a 240-min experimental period (period 2) in which hyperglycemia was matched to period 1 and either no changes were made (CON), a fourfold rise in insulin was created (INS), a portion of the glucose (22.4 mumol.kg-1.min-1) was infused via the portal vein (Po), or a fourfold rise in insulin was created in combination with portal glucose infusion (INSPo). Arterial insulin levels were similar in all groups during period 1 (approximately 45 pM) and were 45 +/- 9, 154 +/- 20, 43 +/- 7, and 128 +/- 14 pM during period 2 in CON, INS, Po, and INSPo, respectively. The hepatic glucose load was similar between periods and among groups (approximately 278 mumol.kg-1.min-1). Net hepatic glucose output was similar among groups during period 1 (approximately 0.1 mumol.kg-1.min-1) and did not change significantly in CON during period 2. In INS net hepatic glucose uptake (NHGU; mumol.kg-1.min-1) was -3.8 +/- 3.3 at 15 min of period 2 and did not reach a maximum (-15.9 +/- 6.6) until 90 min. In contrast, NHGU reached a maximum of -13.0 +/- 3.7 in Po after only 15 min of period 2. In INSPo, NHGU reached a maximum (-23.6 +/- 3.5) at 60 min. Liver glycogen accumulation during period 2 was 21 +/- 10, 84 +/- 17, 65 +/- 16, and 134 +/- 17 mumol/gram in CON, INS, Po, and INSPo, respectively. The increment (period 1 to period 2) in the active form of liver glycogen synthase was 0.7 +/- 0.4, 6.5 +/- 1.2, 2.8 +/- 1.0, and 8.5 +/- 1.3% in CON, INS, Po, and INSPo, respectively. Thus, in contrast to insulin, the portal signal rapidly activates NHGU. In addition, the portal signal independent of a rise in insulin, can cause glycogen accumulation in the liver.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8550854      PMCID: PMC507065          DOI: 10.1172/JCI118410

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  41 in total

1.  Intraportal glucose delivery enhances the effects of hepatic glucose load on net hepatic glucose uptake in vivo.

Authors:  S R Myers; D W Biggers; D W Neal; A D Cherrington
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

Review 2.  Regulation of net hepatic glucose uptake in vivo.

Authors:  M J Pagliassotti; A D Cherrington
Journal:  Annu Rev Physiol       Date:  1992       Impact factor: 19.318

3.  Role of hepatic nerves in response of liver to intraportal glucose delivery in dogs.

Authors:  B Adkins-Marshall; M J Pagliassotti; J R Asher; C C Connolly; D W Neal; P E Williams; S R Myers; G K Hendrick; R B Adkins; A D Cherrington
Journal:  Am J Physiol       Date:  1992-05

4.  Estimation of hepatic blood flow with indocyanine green.

Authors:  C M LEEVY; C L MENDENHALL; W LESKO; M M HOWARD
Journal:  J Clin Invest       Date:  1962-05       Impact factor: 14.808

5.  A rapid method for the determination of para-aminohippuric acid in kidney function tests.

Authors:  C BRUN
Journal:  J Lab Clin Med       Date:  1951-06

6.  Pancreatic glucagon secretion in normal and diabetic subjects.

Authors:  E Aguilar-Parada; A M Eisentraut; R H Unger
Journal:  Am J Med Sci       Date:  1969-06       Impact factor: 2.378

7.  Magnitude of negative arterial-portal glucose gradient alters net hepatic glucose balance in conscious dogs.

Authors:  M J Pagliassotti; S R Myers; M C Moore; D W Neal; A D Cherrington
Journal:  Diabetes       Date:  1991-12       Impact factor: 9.461

8.  Insulin control of glucose metabolism in man: a new kinetic analysis.

Authors:  P A Insel; J E Liljenquist; J D Tobin; R S Sherwin; P Watkins; R Andres; M Berman
Journal:  J Clin Invest       Date:  1975-05       Impact factor: 14.808

9.  Disposition of a mixed meal by the conscious dog.

Authors:  M C Moore; M J Pagliassotti; L L Swift; J Asher; J Murrell; D Neal; A D Cherrington
Journal:  Am J Physiol       Date:  1994-04

10.  Importance of the route of intravenous glucose delivery to hepatic glucose balance in the conscious dog.

Authors:  B A Adkins; S R Myers; G K Hendrick; R W Stevenson; P E Williams; A D Cherrington
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

View more
  39 in total

1.  Pregnancy augments hepatic glucose storage in response to a mixed meal.

Authors:  Mary Courtney Moore; Marta S Smith; Cynthia C Connolly
Journal:  Br J Nutr       Date:  2011-08-11       Impact factor: 3.718

Review 2.  Regulation of hepatic glucose uptake and storage in vivo.

Authors:  Mary Courtney Moore; Katie C Coate; Jason J Winnick; Zhibo An; Alan D Cherrington
Journal:  Adv Nutr       Date:  2012-05-01       Impact factor: 8.701

Review 3.  Specific features of glycogen metabolism in the liver.

Authors:  M Bollen; S Keppens; W Stalmans
Journal:  Biochem J       Date:  1998-11-15       Impact factor: 3.857

4.  Mechanism by which glucose and insulin inhibit net hepatic glycogenolysis in humans.

Authors:  K F Petersen; D Laurent; D L Rothman; G W Cline; G I Shulman
Journal:  J Clin Invest       Date:  1998-03-15       Impact factor: 14.808

5.  Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs.

Authors:  K Rebrin; G M Steil; S D Mittelman; R N Bergman
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

6.  Comparison of the direct and indirect effects of epinephrine on hepatic glucose production.

Authors:  C A Chu; D K Sindelar; D W Neal; E J Allen; E P Donahue; A D Cherrington
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

7.  Glucagon's effect on liver protein metabolism in vivo.

Authors:  Guillaume Kraft; Katie C Coate; Jason J Winnick; Dominique Dardevet; E Patrick Donahue; Alan D Cherrington; Phillip E Williams; Mary Courtney Moore
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-05-23       Impact factor: 4.310

8.  Targeting insulin to the liver corrects defects in glucose metabolism caused by peripheral insulin delivery.

Authors:  Dale S Edgerton; Melanie Scott; Ben Farmer; Phillip E Williams; Peter Madsen; Thomas Kjeldsen; Christian L Brand; Christian Fledelius; Erica Nishimura; Alan D Cherrington
Journal:  JCI Insight       Date:  2019-02-26

9.  Bromocriptine mesylate improves glucose tolerance and disposal in a high-fat-fed canine model.

Authors:  Mary Courtney Moore; Marta S Smith; Larry L Swift; Anthony H Cincotta; Michael Ezrokhi; Nicholas Cominos; Yahong Zhang; Ben Farmer; Alan D Cherrington
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-05-27       Impact factor: 4.310

10.  Portal 5-hydroxytryptophan infusion enhances glucose disposal in conscious dogs.

Authors:  Mary Courtney Moore; Kazuhiro Kimura; Haruki Shibata; Tsutomu Honjoh; Masayuki Saito; Carrie A Everett; Marta S Smith; Alan D Cherrington
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-03-08       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.